Abstract
A case of acquired hemophilia A (AHA) that developed in a patient with autoimmune pancreatitis (AIP) is presented. A 64-year-old woman was diagnosed with AIP in 2007. The symptoms resolved with prednisolone (PSL). Although the dose of PSL was tapered to 7.5 mg/day for maintenance, serum IgG4 levels remained high. She suddenly presented with subcutaneous bleeding in 2015. Her activated partial thromboplastin time was prolonged (80.0 s). A mixing test showed an inhibitor pattern, factor VIII (FVIII) activity was less than 1%, and FVIII inhibitor was 290 BU/mL. She was diagnosed with AHA. Her serum IgG4 was elevated to 133 mg/dL. She was treated first with PSL alone, but she developed bladder tamponade. Cyclophosphamide and activated prothrombin complex concentrate were combined with PSL. She then achieved hemostasis, and FVIII inhibitor disappeared. FVIII inhibitor had been detected since PSL was tapered and AHA recurred two months later. An enzyme-linked immunosorbent assay showed that the inhibitor was mainly IgG4 and IgG1. This case suggests that elevation of IgG4 may be associated with the development of both AHA and AIP.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006;41:613–25.
Fulcher CA, de Graaf Mahoney S, Zimmerman TS. FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting. Blood. 1987;69:1475–80.
Shetty S, Bhave M, Ghosh K. Acquired hemophilia a: diagnosis, an etiology, clinical spectrum and treatment options. Autoimmun Rev. 2011;10:311–6.
Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626–31.
Matsumoto T, Nogami K, Shima M. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity. Int J Hematol. 2017;105:174–83.
Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patient with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.
The Japan Pancreas Society, The Ministry of Health and Welfare Investigation Research Team for Intractable Pancreatic Disease. Clinical diagnostic criteria for autoimmune pancreatitis 2011. Suizo. 2012;27:17–25.
Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, International Association of Pancreatology, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352–8.
Sugino K, Gocho K, Ishida F, Kikuchi N, Hirota N, Sato K, et al. Acquired hemophilia A associated with IgG4-related lung disease in a patient with autoimmune pancreatitis. Intern Med. 2012;51:3151–4.
Nagao Y, Yamanaka H, Harada H. A patient with hypereosinophilic syndrome that manifested with acquired hemophilia and elevated IgG4: a case report. J Med Case Rep. 2012;6:63.
Li X, Duan W, Zhu X, Xu J. Immunoglobulin G4-related acquired hemophilia: a case report. Exp Ther Med. 2016;12:3988–92.
Hofbauer CJ, Whelan SF, Hirschler M, Allacher P, Horling FM, Lawo JP, et al. Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans. Blood. 2015;125:1180–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Narazaki, T., Haji, S., Nakashima, Y. et al. Acquired hemophilia A associated with autoimmune pancreatitis with serum IgG4 elevation. Int J Hematol 108, 335–338 (2018). https://doi.org/10.1007/s12185-018-2441-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-018-2441-3